Skip to main content
. 2021 Nov 29;11:606. doi: 10.1038/s41398-021-01702-2

Fig. 1. The associations of polygenic risk scores (PRS) for bipolar disorder (BD), schizophrenia (SCZ), major depression (MDD), meta-SCZ/MDD/BD (MET3), and meta-SCZ/MDD (MET2) with dichotomous lithium treatment response (Alda total ≥ 7).

Fig. 1

The x-axis refers to the percentage of explained variance in treatment response to lithium accounted for by the PRS (Nagelkerke partial R2). The y-axis plots the PRS for BD, SCZ, MDD, MET3, and MET2. Each bar is labelled with the p-values for the association between the PRS and lithium treatment response.